Overview
Study of ONO-2506 in Patients With Acute Ischemic Stroke
Status:
Completed
Completed
Trial end date:
2008-09-01
2008-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine the efficacy and safety of ONO-2506 compared to placebo in patients with acute ischemic stroke.Phase:
Phase 2/Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Criteria
Inclusion Criteria:1. Subjects who have a clinical diagnosis of acute ischemic stroke
2. Subjects within 72 hours after onset of the stroke
3. Other inclusion criteria may apply.
Exclusion Criteria:
1. Subjects who are scheduled to have surgical operations likely to affect the prognosis
(including intravascular surgery and circulatory reconstruction)
2. Subjects who are pregnant or lactating, or who have child-bearing potential, or who
wish to become pregnant.
3. Other exclusion criteria may apply.